Evidence map›Paper›PMID 29334546›Full record

ArticleAIDS (London, England)2018

Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa.

Catherine E Oldenburg, Jacob Bor, Guy Harling, Frank Tanser, Tinofa Mutevedzi, Maryam Shahmanesh, George R Seage, Victor De Gruttola, Matthew J Mimiaga, Kenneth H Mayer and 2 more

Open access · hybridAbstract read
In one paragraph

Article in AIDS (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Observational
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Catherine E OldenburgDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Jacob BorDepartment of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Guy HarlingAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Frank TanserAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Tinofa MutevedziAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Maryam ShahmaneshAfrica Health Research Institute, KwaZulu-Natal, South Africa.
George R SeageDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Victor De GruttolaDepartment of Biostatistics, Harvard T.H. Chan School of Public Health.
Matthew J MimiagaDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Kenneth H MayerDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Deenan PillayAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Till BärnighausenAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Africa Health Research Institute · ZAHarvard University · USHarvard Global Health Institute · USBoston University · USFenway Health · USRhode Island Department of Health · USUniversity of KwaZulu-Natal · ZA

Funding

HIV and Other Infectious Consequences of Substance UseT32DA013911 · NIDA · MIRIAM HOSPITAL · PI TRACI C GREEN, JOSIAH D RICH · 2001 to 2026
$9.6M
Epidemiology of Infectious Diseases and BiodefenseT32AI007535 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRAD, YONATAN H, MURRAY, MEGAN B · 1998 to 2025
$4.8M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Causal Pathways to population health impact of HIV antiretroviral treatmentR01HD084233 · NICHD · UNIVERSITY OF KWAZULU-NATAL · PI BARNIGHAUSEN, TILL, TANSER, FRANK COURTENEY · 2015 to 2021
$2.3M
Can HIV Hot-Spots be eradicated? An intervention to decrease HIV transmission to young women in rural KwaZulu-Natal South AfricaR01AI124389 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI BARNIGHAUSEN, TILL, TANSER, FRANK COURTENEY · 2016 to 2020
$2.1M
Economic, health, and behavioral dimensions of HIV treatment scale-upK01MH105320 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOR, JACOB · 2015 to 2018
$613k
NIAID NIH HHS R01 AI124389NIAID NIH HHS T32 AI007535NICHD NIH HHS R01 HD084233NIDA NIH HHS T32 DA013911NIMH NIH HHS K01 MH105320NIMH NIH HHS R25 MH083620
6 · The paper itself

Abstract

objectivesWe investigate the effect of immediate antiretroviral therapy (ART) eligibility on HIV incidence among HIV-uninfected household members.

designRegression discontinuity study arising from a population-based cohort.

methodsHousehold members of patients seeking care at the Hlabisa HIV Treatment and Care Programme in rural KwaZulu-Natal South Africa between January 2007 and August 2011 with CD4 cell counts up to 350 cells/μl were eligible for inclusion if they had at least two HIV tests and were HIV-uninfected at the time the index patient linked to care (N = 4115). Regression discontinuity was used to assess the intention-to-treat effect of immediate versus delayed ART eligibility on HIV incidence among household members. Exploiting the CD4 cell count-based threshold rule for ART initiation (CD4 < 200 cells/μl until August 2011), we used Cox proportional hazards models to compare outcomes for household members of patients who presented for care with CD4 cell counts just above versus just below the ART initiation threshold.

resultsCharacteristics of household members of index patients initiating HIV care were balanced between those with an index patient immediately eligible for ART (N = 2489) versus delayed for ART (N = 1626). There were 337 incident HIV infections among household members, corresponding to an HIV incidence of 2.4 infections per 100 person-years (95% confidence interval 2.5-3.1). Immediate eligibility for treatment reduced HIV incidence in households by 47% in our optimal estimate (hazard ratio = 0.53, 95% confidence interval 0.30-0.96), and by 32-60% in alternate specifications of the model.

conclusionImmediate eligibility of ART led to substantial reductions in household-level HIV incidence.

Indexed as

Family HealthHealth Services ResearchAdolescentAdultAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountDisease Transmission, InfectiousFamily CharacteristicsFemaleHIV InfectionsHumansIncidenceLongitudinal StudiesMaleMiddle AgedAnti-Retroviral Agents

Identifiers

PMID29334546
PMCPMC5832606
OpenAlexW2783385530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.